Literature DB >> 20466472

Experience of maxillary sinus floor augmentation in the presence of antral pseudocysts.

Isa M Kara1, Dervişhan Küçük, Serkan Polat.   

Abstract

Sinus floor elevation is increasingly being used with implant placement procedures. However, certain surgical difficulties can develop, such as sinus membrane perforation, bleeding, anatomic variations, or some pathologies of the maxillary sinus. Maxillary antral pseudocysts are one of the most common benign pathologies of the maxillary sinus. Although some investigators have described the presence of this pathology as a contraindication, recent reports have demonstrated that pseudocysts of the maxillary sinus are not a contraindication for sinus augmentation. In these reports, maxillary sinus augmentations related to antral pseudocyst experiences are presented. Crown Copyright 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20466472     DOI: 10.1016/j.joms.2009.09.116

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  4 in total

1.  Assessment of maxillary sinus lifting procedure in the presence of chronic sinusitis, a retrospective comparative study.

Authors:  Abdullah Atef Hammuda; Mohamed Moawad Ghoneim
Journal:  Ann Med Surg (Lond)       Date:  2021-05-08

Review 2.  Open Sinus Lift Surgery and the Importance of Preoperative Cone-Beam Computed Tomography Scan: A Review.

Authors:  Amin Rahpeyma; Saeedeh Khajehahmadi
Journal:  J Int Oral Health       Date:  2015-09

3.  Cyst decreased in size post maxillary sinus floor augmentation surgery in diabetic patient: A case report.

Authors:  Sijia Zhang; Yingliang Song; Hongbo Wei; Shuai Ren
Journal:  Int J Surg Case Rep       Date:  2015-10-19

4.  Sinus lifts in the presence of pseudoantral and mucous retention cysts.

Authors:  Moon Gi Choi; Chang Hyun Hong; Eun Joo Choi; Won Jong Park; Young Geun Kim; Do Geon Gil
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2022-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.